HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity.

Abstract
We recently reported the dual (antihormonal and cytotoxic) functionality of ferrocifens, which are organometallic complexes derived from hydroxytamoxifen, the standard molecule in the treatment of hormone-dependent breast cancers. To test the hypothesis that the presence of a ferrocenyl substituent on molecules with an affinity for the estrogen receptor is sufficient to give them cytotoxic properties in vitro, we prepared complexes derived from estradiol with a ferrocenyl substituent at positions 7alpha and 17alpha. The complexes thus obtained retain a satisfactory level of affinity for the estrogen receptor (RBA values higher than 12 %). At low concentrations (0.1-1 microM) the complexes show an estrogenic effect in vitro equivalent to that of estradiol on hormone-dependent (MCF-7) breast cancer cells, and no cytotoxic effect on hormone-independent (MDA-MB-231) breast cancer cells. At high concentrations (up to 50 microM) the 17alpha-ethynylferrocenyl estradiol and 7alpha-ferrocenylmethylthio estradiol become cytotoxic (IC(50)=13.2 microM and 18.8 microM, respectively) while the 17alpha-ferrocenylestradiol remains non toxic. The low toxicity of these compounds support our hypothesis that electronic communication between the ferrocenyl and phenol moieties in the hydroxyferrocifens series is a key parameter in the generation of cytotoxic effects at submicromolar concentrations.
AuthorsAnne Vessières, Daniela Spera, Siden Top, Boguslav Misterkiewicz, Jan-Martin Heldt, Elizabeth Hillard, Michel Huché, Marie-Aude Plamont, Elio Napolitano, Rita Fiaschi, Gérard Jaouen
JournalChemMedChem (ChemMedChem) Vol. 1 Issue 11 Pg. 1275-81 (Nov 2006) ISSN: 1860-7179 [Print] Germany
PMID17022106 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Estrogens
  • Ferrous Compounds
  • Metallocenes
  • Receptors, Estrogen
  • ferrocene
Topics
  • Antineoplastic Agents (chemistry, metabolism, pharmacology)
  • Breast Neoplasms (pathology)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Electrochemistry
  • Estrogens (chemistry)
  • Ferrous Compounds (chemistry)
  • Humans
  • Metallocenes
  • Models, Molecular
  • Receptors, Estrogen (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: